MINIRIN
LOE ApproachingNDANASALSPRAY, METERED
Approved
Sep 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
8
Data completeness
2/8 — Basic
Drug data last refreshed 6d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MINIRIN is a nasal spray formulation of desmopressin approved for nocturnal enuresis (bedwetting) in pediatric and adult patients. It works as a vasopressin analog that reduces urine production by increasing water reabsorption in the kidneys. This mechanism makes it a targeted therapy for nighttime incontinence management.
LOE Approaching
Product is in late-stage lifecycle with approaching loss of exclusivity; commercial teams should expect resource reallocation toward pipeline products or defensive market-share strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (8)
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
Started May 2020
1,087 enrolled
Nocturia Due to Nocturnal Polyuria
Study of Minirin Melt® in Adult Patients With Nocturia
Started Jul 2015
835 enrolled
Nocturia
A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia
Started Mar 2012
4,136 enrolled
Nocturia
A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
Started Jan 2011
20 enrolled
Central Diabetes Insipidus
Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
Started Jul 2010
116 enrolled
Nocturia
Worked on MINIRIN at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.